TotalSeq™-A0828 anti-human CD307d (FcRL4) | BioLegend 340209 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

BioLegend

other brands :

Babco, Signet, Sternberger Monoclonals, Senetek, Covance

product type :

antibody

product name :

TotalSeq™-A0828 anti-human CD307d (FcRL4)

catalog :

340209

quantity :

10 μg

price :

358 USD

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

413D12

The same clone is also sold as:

Invitrogen: 17-3079-41, 17-3079-42, 46-3079-42

reactivity :

human

citations: 1

Reference
Jiang G, Shi L, Zheng X, Zhang X, Wu K, Liu B, et al. Androgen receptor affects the response to immune checkpoint therapy by suppressing PD-L1 in hepatocellular carcinoma. Aging (Albany NY). 2020;12:11466-11484 pubmed publisher

product information

Antigen :

CD307d

Apps. Abbrev. :

Cat # :

340209

Clone :

413D12

Item :

TotalSeq™-A0828 anti-human CD307d (FcRL4)

Isotype :

Mouse IgG2b, κ

Other Names :

FcRL4 (Fc receptor-like 4), IRTA1, IGFP2

Size :

10 μg

Price (USD) :

358 USD

Reactivity :

Human

Clonality :

Monoclonal

Host :

Mouse

Conjugate/Tag/Label :

TOTALSEQ_A

Immunogen :

P815 cells transfected with FcRL4

Application Notes :

Additional reported applications (with relevant formats) include: immunoprecipitation and blocking. mAb 413D12 is able to block the binding of FcRL4 to aggregated IgA, IgG3, and IgG4.